Skip to main content
Medistim logo

Medistim — Investor Relations & Filings

Ticker · MEDI ISIN · NO0010159684 LEI · 5967007LIEEXZXJOX483 OL Manufacturing
Open in API
Filings indexed 783 across all filing types
Latest filing 2017-02-27 Notice of Dividend Amou…
Country NO Norway
Listing OL MEDI

About Medistim

https://medistim.com/

Medistim is a medical technology company specializing in intraoperative quality assessment solutions. A pioneer and market leader in Transit Time Flow Measurement (TTFM), the company develops and manufactures advanced medical devices for use during surgical procedures. Its flagship MiraQ™ system uniquely combines TTFM with high-frequency ultrasound imaging, providing surgeons with real-time data to verify graft function and blood flow. This technology is applied in cardiac, vascular, and transplant surgery to enhance procedural quality control and improve patient outcomes.

Recent filings

Filing Released Lang Actions
Foreslått utbytte i Medistim ASA
Notice of Dividend Amount Classification · 98% confidence The document text is very short (569 characters) and explicitly announces a proposed dividend ('Foreslått utbytte') of NOK 1.75 per share, detailing the ex-date, record date, and payment date. This directly corresponds to the definition of 'Notice of Dividend Amount' (DIV). It is not a full report, a management change, or a general regulatory filing, but a specific announcement about a dividend.
2017-02-27 Norwegian
Resultat for 4 kvartal 2016 og foreløpig regnskap for 2016 for Medistim ASA
Interim / Quarterly Report Classification · 100% confidence The document is a comprehensive financial report titled '4. kvartal og foreløpig årsregnskap 2016' (Q4 and preliminary annual accounts 2016). It contains detailed financial statements, including revenue, EBIT, balance sheet data, cash flow, and operational analysis for the specified period. It is not an announcement of a report, but the report itself, and it provides substantive financial data, fitting the definition of an Interim/Quarterly Report. Q4 2016
2017-02-17 Norwegian
Results for fourth quarter and preliminary results for 2016 for Medistim
Interim / Quarterly Report Classification · 100% confidence The document is a comprehensive financial report for the fourth quarter and full year 2016. It contains detailed financial statements, including sales, operating profit (EBIT), balance sheet data, cash flow, and operational analysis by region. It is not an announcement of a report (RPA) or a simple earnings release (ER) as it provides extensive financial analysis and data tables. Therefore, it is classified as an Interim/Quarterly Report. Q4 2016
2017-02-17 English
Resultat for 4 kvartal 2016 og foreløpig regnskap for 2016 for Medistim ASA
Investor Presentation Classification · 99% confidence The document is titled "Medistim ASA Fourth Quarter 2016" and contains detailed financial statements (Profit and loss for Q4 2016 and Year to date, Balance sheet as of 31.12.2016), operational highlights, segment updates, and strategic outlook. This structure, focusing on comprehensive financial results for a specific fiscal period (a quarter), strongly indicates a report detailing periodic financial performance. Since it is a comprehensive report for a period shorter than a year (Q4), it aligns best with the definition of an Interim / Quarterly Report (IR). It is not an Earnings Release (ER) because it contains full financial tables and detailed analysis, not just highlights. It is also not a 10-K as it covers only one quarter, not the full year's audited results.
2017-02-17 Norwegian
Results for fourth quarter and preliminary results for 2016 for Medistim
Investor Presentation Classification · 99% confidence The document is titled "Medistim ASA Fourth Quarter 2016" and contains detailed financial statements (Profit and loss for Q4 2016 and Year to date, Balance sheet as of 31.12.2016), operational highlights, segment updates, and strategic outlook. This structure, focusing on comprehensive financial results for a specific fiscal period (a quarter), strongly indicates a report detailing periodic financial performance. Since it is a comprehensive report for a period shorter than a year (Q4), it aligns best with the definition of an Interim / Quarterly Report (IR). It is not an Earnings Release (ER) because it contains full financial tables and detailed analysis, not just highlights. It is also not a 10-K as it covers only one quarter, not the full year's audited results.
2017-02-17 English
Resultat for 4 kvartal 2016 og foreløpig regnskap for 2016 for Medistim ASA
Earnings Release Classification · 100% confidence The document text explicitly states 'Resultat for 4 kvartal 2016 og foreløpig regnskap for 2016' (Results for Q4 2016 and preliminary accounts for 2016). It contains key financial metrics for the quarter and the full year (revenue, EBIT, dividend proposal). This content structure—summarizing period results and providing key figures—is characteristic of an Earnings Release (ER) or an Interim/Quarterly Report (IR). Since it covers the full year (2016) results, it leans towards an annual summary, but the format is brief and focused on highlights rather than the comprehensive detail expected in a 10-K. Given the focus on quarterly results and key highlights, 'ER' (Earnings Release) is the most appropriate classification, as it is the initial announcement of periodical financial results. Q4 2016
2017-02-17 Norwegian

Browse filings by year

15 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.